Five different PCR methods for the detection of Helicobacter pylori were evaluated. The results of this study indicate that of the five PCR methods examined, the ureC (glmM) gene PCR is the most sensitive and specific for the detection of H. pylori in gastric biopsy specimens.
Helicobacter pylori is an etiologic agent of chronic active gastritis and gastric and duodenal ulcers (6, 12) . Many PCR methods have been developed to detect the organism directly in clinical specimens. The targets of these PCR methods include the 16S rRNA gene (8) , the random chromosome sequence (17) , the 26-kDa species-specific antigen (SSA) gene (7, 14) , the urease A (ureA) gene (3) , and the urease C (ureC) gene (1) . The ureC gene has been shown to encode the phosphoglucosamine mutase, which is unrelated to urease production, and was renamed the glmM gene (4) . To determine which PCR method is most appropriate to use, we compared the sensitivities and the specificities of five different PCR methods for the detection of H. pylori in gastric biopsy specimens.
The specimens used for this study were gastric biopsy samples from patients who had undergone endoscopy for diagnosis of abdominal pain or discomfort. Three pieces of gastric tissue were taken from each patient. The use of these specimens for research was approved by the internal review board of the Tri-Service General Hospital, Taipei, Taiwan. No histopathology was performed on these tissues in this study. These three pieces of tissue were pooled and ground together. An aliquot of the tissue homogenate was used for culture, and the remain- ing was used for PCR. H. pylori culture and identification were performed as described previously (9) . For PCR, DNA was isolated from 100 l of tissue homogenate by using the Puregene DNA isolation kit (Gentra Systems, Inc., Minneapolis, Minn.) according to the manufacturer's instructions. Ten microliters (100 ng) of DNA was used as the template for each PCR. Each sample was examined by five different PCR methods. The PCRs were performed as described previously (1, 3, 7, 8, 17) . The primer sequences, conditions, and sizes of these PCR methods are summarized in Table 1 .
The specificities of the five PCR methods were first examined for 15 Bacterial DNA was also isolated by using the Puregene DNA isolation kit (Gentra Systems). None of the PCR methods produced any PCR products from these 15 different bacteria. To determine whether these negative PCR results were false due to the presence of PCR inhibitors, these bacterial samples were examined by the bacterial universal PCR (11) with primers U1 (5Ј-CGGTTACCTTGTTACGACTT-3Ј) and U2 (5Ј-CCTTGTACACACCGCCCGTC-3Ј). All 15 bacterial samples were positive in this universal PCR.
All 24 culture-positive specimens were positive in the 16S rRNA gene, the SSA gene, and the ureC (glmM) gene PCRs. Only 18 of the 24 culture-positive specimens were positive in the ureA gene PCR, and 9 were positive in the random chromosome sequence PCR. One of the 26 culture-negative specimens was positive in all five PCRs, indicating that this specimen was false negative in culture. Twelve of the remaining 25 culture-negative specimens were positive in the 16S rRNA gene PCR, and 10 were positive in the SSA gene PCR. All of these 25 culture-negative specimens were negative in the ureC (glmM) gene, the ureA gene, and the random chromosome sequence PCRs (Table 2) .
To determine the sensitivities of these PCR methods, a 10-fold serial dilution, from 10 ng to 1 fg, of a purified H. pylori DNA was made. Each dilution was examined by all five PCRs. The 16S rRNA gene PCR was determined to have a sensitivity of 0.01 pg of H. pylori DNA, which corresponds to approximately 5 organisms. The sensitivity of the other four PCR methods was found to be 10-fold (0.1 pg) lower than that of the 16S rRNA gene PCR. This is conceivable since the 16S rRNA gene PCR is a seminested PCR and the other four methods are single-step PCRs. However, the 16S rRNA gene PCR has a very poor specificity. It produced positive results with 13 of the 26 culture-negative biopsy specimens as described above. This finding is consistent with the previous report that the 16S rRNA gene PCR nonspecifically amplifies human DNA (2). Unfortunately, the 16S rRNA gene PCR has been the most widely used method for the detection of H. pylori in clinical specimens (10, 11, 13, 15, 18) . The SSA gene PCR was also found to have a problem with specificity in this study. Although this PCR did not amplify any of the other bacterial DNAs, it amplified 10 of the 25 H. pylori culture-negative biopsy specimens. It is highly unlikely that all 10 samples were false negative by culture. The reasons for this poor sensitivity remain to be investigated.
The ureA gene and the random sequence PCRs appeared to be specific for H. pylori, but the sensitivities of these two methods were unsatisfactory. The random sequence PCR amplified only 38% (9 of 24) of H. pylori culture-positive biopsy samples, and the ureA gene PCR amplified 75% (18 of 24) of them. This low sensitivity may be due to sequence polymorphism in these two loci (5, 16, 17) .
The ureC (glmM) gene PCR amplified all 24 H. pylori culture-positive biopsy specimens (positive predictive value, 100%) ( Table 3 ) and produced only one false-positive result on 26 H. pylori culture-negative specimens (negative predictive value, 96%) ( Table 3) or other bacterial DNA. However, this specimen was very likely false negative in culture because it was positive in all five PCRs, as mentioned above, and the patient had symptoms typical of H. pylori gastritis according to endoscopic examination. Although the sensitivity of the ureC (glmM) gene PCR was found to be 10 times lower (50 organisms) than that of the 16S rRNA gene PCR, the results of this study suggest that it has sufficient sensitivity for clinical applications. We therefore consider the ureC (glmM) gene PCR to be the most appropriate of the five different PCR methods examined for detection of H. pylori organisms in clinical specimens. 
